Display options
Cite
Dodd N, Carey ML, Mansfield E, et al. Testing the Effectiveness of a Primary Care Intervention to Improve Uptake of Colorectal Cancer Screening: A Randomized Controlled Trial Protocol. JMIR Res Protoc. 2017;6(5):e86doi: 10.2196/resprot.7432.
Dodd, N., Carey, M. L., Mansfield, E., & Oldmeadow, C. (2017). Testing the Effectiveness of a Primary Care Intervention to Improve Uptake of Colorectal Cancer Screening: A Randomized Controlled Trial Protocol. JMIR research protocols, 6(5), e86. https://doi.org/10.2196/resprot.7432
Dodd, Natalie, et al. "Testing the Effectiveness of a Primary Care Intervention to Improve Uptake of Colorectal Cancer Screening: A Randomized Controlled Trial Protocol." JMIR research protocols vol. 6,5 (2017): e86. doi: https://doi.org/10.2196/resprot.7432
Dodd N, Carey ML, Mansfield E, Oldmeadow C. Testing the Effectiveness of a Primary Care Intervention to Improve Uptake of Colorectal Cancer Screening: A Randomized Controlled Trial Protocol. JMIR Res Protoc. 2017 May 10;6(5):e86. doi: 10.2196/resprot.7432. PMID: 28490420; PMCID: PMC5443911.
Copy Download .nbib Format: NLM
Share it on

JMIR Res Protoc. 2017 May 10;6(5):e86. doi: 10.2196/resprot.7432.

Testing the Effectiveness of a Primary Care Intervention to Improve Uptake of Colorectal Cancer Screening: A Randomized Controlled Trial Protocol.

JMIR research protocols

Natalie Dodd, Mariko Leanne Carey, Elise Mansfield, Christopher Oldmeadow

Affiliations

  1. University of Newcastle, School of Medicine and Public Health, Faculty of Health and Medicine, Callaghan, Australia.
  2. Hunter Medical Research Institute, New Lambton Heights, Australia.
  3. Hunter Medical Research Institute, Clinical Research Design, Information Technology and Statistical Support, New Lambton Heights, Australia.

PMID: 28490420 PMCID: PMC5443911 DOI: 10.2196/resprot.7432

Abstract

BACKGROUND: Screening for colorectal cancer (CRC) significantly reduces mortality associated with this disease. In Australia, the National Bowel Cancer Screening Program provides regular fecal occult blood tests (FOBT) for those aged 50 to 74 years, however, participation rates in the program have plateaued at 36%. Given low uptake in the National Bowel Cancer Screening Program, it is necessary to explore alternate methods to increase CRC screening rates. Primary care is a promising adjunct setting to test methods to increase CRC screening participation. Primary care guidelines support the recommendation and provision of CRC screening to primary care patients. Those in the National Bowel Cancer Screening Program target age range frequently present to their primary care provider.

OBJECTIVE: This study tests the effect that a multicomponent primary care-based intervention has on CRC screening uptake when compared to usual care.

METHODS: Primary care patients presenting for an appointment with their primary care provider complete a touchscreen survey to determine eligibility for the trial. Those aged 50 to 74 years, at average risk of CRC, with no history of CRC or inflammatory bowel disease, who have not had an FOBT in the past 2 years or a colonoscopy in the past 5 years are eligible to participate in the trial. Trial participants are randomized to the intervention or usual care group by day of attendance at the practice. The intervention consists of provision of an FOBT, printed information sheet, and primary care provider endorsement to complete the FOBT. The usual care group receives no additional care.

RESULTS: The primary outcome is completion of CRC screening 6 weeks after recruitment. The proportion of patients completing CRC screening will be compared between trial groups using a logistic regression model.

CONCLUSIONS: CRC screening rates in Australia are suboptimal and interventions to increase screening participation are urgently required. This protocol describes the process of implementing a multicomponent intervention designed to increase CRC screening uptake in a primary care setting.

TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12616001299493; https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371136&isReview=true (Archived by WebCite at http://www.webcitation.org/6pL0VYIj6). Universal Trial Number U1111-1185-6120.

©Natalie Dodd, Mariko Leanne Carey, Elise Mansfield, Christopher Oldmeadow. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 10.05.2017.

Keywords: clinical trial; colorectal cancer; early detection of cancer; general practice; primary care; primary care provider

References

  1. Cancer. 2007 Nov 1;110(9):2083-91 - PubMed
  2. Cancer Epidemiol. 2010 Oct;34(5):604-10 - PubMed
  3. J Gen Intern Med. 1999 Jul;14(7):432-7 - PubMed
  4. J Gen Intern Med. 2009 Nov;24(11):1192-7 - PubMed
  5. Ann Intern Med. 2012 Mar 6;156(5):I30 - PubMed
  6. J Med Screen. 2002;9(4):147-52 - PubMed
  7. BMC Public Health. 2013 May 13;13:464 - PubMed
  8. N Engl J Med. 2013 Sep 19;369(12):1106-14 - PubMed
  9. Am J Public Health. 2006 May;96(5):809-11 - PubMed
  10. Br J Cancer. 2011 Aug 9;105(4):475-80 - PubMed
  11. Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):587-93 - PubMed
  12. N Engl J Med. 2000 Nov 30;343(22):1603-7 - PubMed
  13. Lancet. 1996 Nov 30;348(9040):1467-71 - PubMed
  14. Ann Intern Med. 2010 May 18;152(10):668-76 - PubMed
  15. Fam Pract. 2011 Dec;28(6):670-6 - PubMed
  16. Med Care. 2005 Sep;43(9):939-44 - PubMed
  17. Prev Med. 2014 Feb;59:19-24 - PubMed
  18. Gut. 2002 Jun;50(6):840-4 - PubMed
  19. Health Promot J Austr. 2015 Apr;26(1):39-44 - PubMed
  20. ISRN Oncol. 2014 Mar 05;2014:425787 - PubMed
  21. Eur J Cancer Prev. 2008 Oct;17(5):430-7 - PubMed
  22. Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):509-21 - PubMed
  23. Gut. 2015 Jul;64(7):1158-77 - PubMed
  24. J Gen Intern Med. 2007 Dec;22(12):1681-8 - PubMed
  25. N Engl J Med. 1993 May 13;328(19):1365-71 - PubMed

Publication Types